Delivery Order SPE2DB20D3101-SPE2DB24FRRH4

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order, valued at $1,995.26, is for the supply of Lamotrigine ER 250 mg tablets. The contract is a firm-fixed-price Delivery Order with an ultimate completion date of September 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
The federal contract award is for the supply of the medication Lamotrigine ER 250 mg tablets to the Defense Logistics Agency (DLA). The $4,284.45 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 9, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,944.30, is for the delivery of Lamotrigine ODT 100 mg tablets. This is a delivery order contract with a firm-fixed price pricing type. The contract has an ultimate completion date of August 9, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $2,990.78 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for Lamotrigine ER 50 mg tablets. This order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lamotrigine ER 50 mg tablets. The contract is a firm-fixed price arrangement with a ceiling value of $7,987.56 and a period of performance through August 13, 2024. This award does not utilize any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp to provide Lamotrigine ER 50 mg tablets. The award is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military healthcare programs and facilities worldwide....
This federal contract award, valued at $1,043.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4567998899 LAMOTRIGINE ER 200 MG TABLET 30S, with an ultimate completion date of April 23, 2025. The contract is a firm fixed-price, non-set-aside arrangement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,428.90 firm fixed-price delivery order contract is for the supply of 4567983871 - Lamotrigine ER 300 mg Tablets. The contract has an ultimate completion date of April 22, 2025 and is not set aside. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4565018959 LAMOTRIGINE ODT 100 MG TABLET 30S. The contract has a ceiling value of $1,764.07 and is a Firm Fixed Price Delivery Order with an ultimate completion date of June 28, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 27, 2024. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Lamotrigine ODT 100 mg tablets. The contract has a potential value of $2,958.34 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This delivery order is part of a larger indefinite delivery contract (IDC)...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRRH4
    Delivery Order

This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,085.64, is a firm-fixed-price delivery order with an ultimate completion date of August 1, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract award is not designated as a set-aside and represents open competition. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 2/27/25, 10:01 AM